To evaluate whether AFP immunization can be effective against AFP(+) HCC, we applied the c-MYC/Mcl1–induced mouse HCC model by hydrodynamic tail vein injection (HDTVi), which exhibited high Afp expression in tumor cells (Supplemental Figure 2, A and B) (14–16). Here, MCL1 is linked to neoplasm.